Table 1:
Demographic, clinical, and outcome data for all patients
| Extra-Adrenal Metastases (n=83) | Isolated Adrenal Metastases (n=91) | Total (n=174) | |
|---|---|---|---|
| Age, yrs (Median, IQR) | 60.0 (51.0 – 67.0) | 65.0 (54.0 – 71.0) | 62.0 (53-70) |
| Gender | |||
| Female | 38 (46%) | 35 (38%) | 73 (42%) |
| Male | 45 (54%) | 56 (62%) | 101 (58%) |
| Primary Site | |||
| NSCLC | 20 (24%) | 48 (53%) | 68 (39%) |
| Renal | 11 (13%) | 23 (25%) | 34 (20%) |
| Colorectal | 18 (22%) | 0 (0%) | 18 (10%) |
| Melanoma | 6 (7%) | 5 (5%) | 11 (6%) |
| HCC | 3 (4%) | 7 (8%) | 10 (6%) |
| Sarcoma | 7 (8%) | 1 (1%) | 8 (5%) |
| Other | 18 (22%) | 7 (8%) | 25 (14%) |
| Operation time (Median, IQR) | 178.0 (140-235) | 162.0 (121-230) | 172.5 (126.5-231.5) |
| Operation Approach | |||
| Laparoscopic | 34 (41%) | 37 (41%) | 71 (41%) |
| Open | 49 (59%) | 54 (59%) | 103 (59%) |
| Median LOS (Median, IQR) | 4.00 (2-7) | 4.00 (2-7) | 4.00 (2.0-7.0) |
| Margin | |||
| Negative | 20 (24%) | 16 (18%) | 36 (21%) |
| Positive | 62 (75%) | 75 (82%) | 137 (79%) |
| Unknown | 1 (1%) | 0 (0%) | 1 (1%) |
| Synchronous Disease | |||
| Yes | 33 (40%) | 29 (32%) | 62 (36%) |
| No | 50 (60%) | 62 (68%) | 112 (64%) |
| Median Tumor size (cm) (Median,IQR) | 4.00 (3.0-6.0) | 4.60 (2.8-7.6) | 4.50 (3.0-7.0) |